Monday, February 16, 2026
25.9 C
Bengaluru

Inspirational Frontline Leadership

[wpfilebase tag=file id=85 tpl=download-button /]

Inside this Issue

1. The Dead Sea Effect in Talent Management by K. Hariram
How to avert the flight of top talent from your organization.

2. The Audit Mindset: The Key to Successful Implementation of Compliance Practices in Pharma by Diksha Fouzdar
For companies to become and stay compliant, a thorough change in mindset is needed – from an adhoc approach to a systems approach.

3. Emotional Marketing: From ‘Needs’ to ‘Wants’ by Vivek Hattangadi
Different emotions trigger different actions – a look into different emotional states and how they can be put to use in pharma marketing.

4. Top 20 Things Every Digital Health Marketer Should Know by Dr. Ashwin Bonde
The importance of preparing for the next level of your career by acquiring the requisite knowledge, skills and attitude before you get there.

Hot this week

Why the World Still Doesn’t Celebrate Antibiotic Breakthroughs llike Zaynich

When a new cancer drug shows promise, it trends...

From Overuse to Overreaction: Recalibrating India’s C-Section Debate

India’s caesarean section debate is drifting toward polarisation. On one...

Sanofi’s Decision not to Renew Paul Hudson as CEO Marks a Structural Shift

In big pharma, leadership changes are rarely impulsive. They...

THE ENCUBE ETHICALS PLAYBOOK: FROM GOA WORKSHOP TO $2BN+ GLOBAL DEAL

How a niche Indian topicals manufacturer outgrew its CDMO...

Indian Pharma: Are Regulatory Gaps From Generics Following Biosimilars?

Transparency, Trust, and the Problem of “Invisible Evidence” in...

Topics

From Overuse to Overreaction: Recalibrating India’s C-Section Debate

India’s caesarean section debate is drifting toward polarisation. On one...

Sanofi’s Decision not to Renew Paul Hudson as CEO Marks a Structural Shift

In big pharma, leadership changes are rarely impulsive. They...

THE ENCUBE ETHICALS PLAYBOOK: FROM GOA WORKSHOP TO $2BN+ GLOBAL DEAL

How a niche Indian topicals manufacturer outgrew its CDMO...

Indian Pharma: Are Regulatory Gaps From Generics Following Biosimilars?

Transparency, Trust, and the Problem of “Invisible Evidence” in...

The Uncomfortable Truth about Indian Generics: Untangling the Conundrum

India’s pharmaceutical industry occupies a unique and powerful position...

IQVIA vs. PharmaTrac: Indian Pharma Market Data

Here is an analytical blog comparing the IQVIA MFR...
spot_img

Related Articles

spot_imgspot_img
Previous article
Next article